5 ML elosulfase alfa 1 MG/ML Injection [Vimizim]
- RxCUI
- 1490052
- RxNorm name
- 5 ML elosulfase alfa 1 MG/ML Injection [Vimizim]
- Display name
- 5 ML elosulfase alfa 1 MG/ML Injection [Vimizim]
- Full name
- 5 ML elosulfase alfa 1 MG/ML Injection [Vimizim]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125460 | Vimizim | elosulfase alfa | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VIMIZIM | ELOSULFASE ALFA | BioMarin Pharmaceutical Inc. | 0caa2565-12b2-0ad0-1f9a-273e81c3d4cc | 2025-10-30 | Boxed warning, Warnings, Adverse reactions | 1490052 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0caa2565-12b2-0ad0-1f9a-273e81c3d4cc | 5 ML elosulfase alfa 1 MG/ML Injection [Vimizim] | SBD | 38 | These highlights do not include all the information needed to use VIMIZIM safely and effectively. See full prescribing information for VIMIZIM. VIMIZIM (elosulfase alfa) injection, for intravenous use Initial U.S. Approval: 2014 | 20251030 |
| 0caa2565-12b2-0ad0-1f9a-273e81c3d4cc | Vimizim 5 MG per 5 ML Injection | SY | 38 | These highlights do not include all the information needed to use VIMIZIM safely and effectively. See full prescribing information for VIMIZIM. VIMIZIM (elosulfase alfa) injection, for intravenous use Initial U.S. Approval: 2014 | 20251030 |
| 0caa2565-12b2-0ad0-1f9a-273e81c3d4cc | 5 ML Vimizim 1 MG/ML Injection | SY | 38 | These highlights do not include all the information needed to use VIMIZIM safely and effectively. See full prescribing information for VIMIZIM. VIMIZIM (elosulfase alfa) injection, for intravenous use Initial U.S. Approval: 2014 | 20251030 |
| 0caa2565-12b2-0ad0-1f9a-273e81c3d4cc | Vimizim 5 MG in 5 ML Injection | PSN | 38 | These highlights do not include all the information needed to use VIMIZIM safely and effectively. See full prescribing information for VIMIZIM. VIMIZIM (elosulfase alfa) injection, for intravenous use Initial U.S. Approval: 2014 | 20251030 |